This topic contains a solution. Click here to go to the answer

Author Question: A client is receiving total parenteral nutrition (TPN) via a central line. Which condition ... (Read 80 times)

MirandaLo

  • Hero Member
  • *****
  • Posts: 538
A client is receiving total parenteral nutrition (TPN) via a central line. Which condition predisposes this client to infection?
 
  a. High protein content in the TPN
  b. WBC count of 7800/mm
  c. Line being in a small IV line
  d. Glucose content of the solution

Question 2

The most likely candidate for total parenteral nutrition is the client:
 
  a. with a low risk of aspiration.
  b. with a well-functioning GI tract.
  c. without intravenous access.
  d. diagnosed with malnutrition and cancer.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

shoemake

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

ANS: D
Glucose creates a medium for bacterial growth.

Answer to Question 2

ANS: D
Clients with malnutrition, cancer, and other conditions are best served with parenteral therapy.




MirandaLo

  • Member
  • Posts: 538
Reply 2 on: Jul 23, 2018
:D TYSM


cici

  • Member
  • Posts: 325
Reply 3 on: Yesterday
Gracias!

 

Did you know?

The word drug comes from the Dutch word droog (meaning "dry"). For centuries, most drugs came from dried plants, hence the name.

Did you know?

The strongest synthetic topical retinoid drug available, tazarotene, is used to treat sun-damaged skin, acne, and psoriasis.

Did you know?

There are more sensory neurons in the tongue than in any other part of the body.

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library